Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Dr. Attila Endre Pavlath Joins the Board of Directors of ComInnex Inc.

Published: Saturday, August 09, 2014
Last Updated: Saturday, August 09, 2014
Bookmark and Share
Dr. Pavlath’s achievements recognized by ACS at the 248th National Meeting & Exposition in San Francisco.

ComInnex, Inc. has announced that Dr. Attila Endre Pavlath joined its Board of Directors.

Dr. Attila Endre Pavlath, a well known scientist and former ACS president will bring his strategic experience into the governing body of ComInnex. Dr. Pavlath’s 6 decades of achievements are also recognized by the American Chemical Society at a dedicated session at the ACS 248th National Meeting & Exposition in San Francisco on August 12th , 2014 at 8:00 am. (ww.acs.org).

ComInnex is a chemistry and medicinal chemistry service organization with strong interest and background in the development of chemical technologies that enables its partners to access novel chemical space and intellectual property. Its current technology innovation platform focuses on the development of synthetic tools towards novel non-flat fragment-like and lead-like molecules for lead identification and medicinal chemistry. To this end the company recently introduced its Smartdiversity™ platform that rapidly creates new IP space for medicinal chemistry.

ComInnex technologies enable the company to penetrate chemical space not easily reachable by traditional laboratory techniques and develop unique and patentable molecular frameworks of high value for the pharmaceutical, agrochemical and chemical industries.

Dr. Ferenc Darvas, President and Chairman of ComInnex commented that “We are proud that Dr. Pavlath joins our Governing Board. We believe that his experience and significant
achievements will be a great asset for the company and will help expand our value added innovative portfolio of offerings.”

Dr. Pavlath added that “I am glad that I could join such a dynamic and innovative company like ComInnex at the governing level and join the experienced industry veterans in the management and Board level such as Dr. Ferenc Darvas, Dr. Gergely Makara and Dr. Laszlo Urge. I believe that together we will create and execute a strategy that will benefit customers significantly and keep ComInnex in the forefront of innovation.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
New Diabetes Drug has Unexpected Side Effect
A type of drug used to treat diabetes may reduce the risk of developing Parkinson’s disease, according to new research.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Cannabis May Be Used to Treat Fractures
TAU researcher finds non-psychotropic compound in marijuana can help heal bone fissures.
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
Creating More Potent Vaccines
Yale researchers uncovered a new role for a type of immune cell, known as regulatory T cells, in promoting long-term immunity.
Potential Therapeutic for Blinding Eye Disease
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Global Search for Next Antibiotic
University of Queensland researchers have launched a global search to discover antibiotics capable of combating superbug bacteria that are resistant to current antibiotics.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!